Evidence map›Paper›PMID 41244408›Full record

ArticleACS omega2025

Interaction of Nanoparticles with Multidrug-Resistant Bacteria.

Raman Preet Singh, Priya Hiteshi, Ankita Sharma, Deepak Kumar, Taranpreet Kaur

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Raman Preet SinghSchool of Pharmaceutical Sciences, Shoolini University, Solan-Oachghat-Kumarhatti Highway, Bajhol, Solan, Himachal Pradesh 173 229, India.ORCID https://orcid.org/0000-0002-2714-0068
Priya HiteshiSchool of Pharmaceutical Sciences, Shoolini University, Solan-Oachghat-Kumarhatti Highway, Bajhol, Solan, Himachal Pradesh 173 229, India.
Ankita SharmaSchool of Pharmaceutical Sciences, Shoolini University, Solan-Oachghat-Kumarhatti Highway, Bajhol, Solan, Himachal Pradesh 173 229, India.
Deepak KumarSchool of Pharmaceutical Sciences, Shoolini University, Solan-Oachghat-Kumarhatti Highway, Bajhol, Solan, Himachal Pradesh 173 229, India.ORCID https://orcid.org/0000-0003-2241-0054
Taranpreet KaurDepartment of Biotechnology, Government Mohindra College, Lower Mall Road, Lower Mall, Patiala, Punjab 147 001, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infections due to drug-resistant bacteria have emerged as a global health risk and are expected to grow at an alarming rate in the coming decades. The number of new antibacterial compounds under preclinical and clinical development is dismayingly low; thus, efforts are underway to either increase the activity of existing compounds or identify other alternatives. Nanoparticles (NPs) have been shown to possess antimicrobial properties along with the ability to improve the activity of existing antimicrobial drugs, including against bacteria. The present study evaluated the effects of carbon nanotubes, graphene, and silver NPs against drug-resistant

Identifiers

PMID41244408
PMCPMC12612964

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.